… therapy strategies for the treatment of Parkinson’s disease: … in patients and animal models
of Parkinson’s disease, with a … stem cells in subchronic MPTP-induced Parkinson’s disease …

… region is an innovative treatment strategy for a wide range of … have shown encouraging
outcomes in the treatment of stroke, … levels in the brain of an Alzheimer’s disease mouse model, …

… promise for improving our understanding of neurodegenerative diseases and advancing
innovative therapeutic strategies. … protects MPTP-induced mouse model of Parkinson’s disease …

… to explore and develop therapeutic strategies aimed at … MPTP-induced PD is a well-established
model for PD. The … samples collected from experimental animal models of AD have …

… now become promising candidates as therapeutic agents … inhibitors are a therapeutic strategy
targeting neurodegeneration… MPP- and MPTP-induced neurotoxicity in animal models (Yu …

… neuropathological feature in Parkinson’s disease, these … promising treatment option aimed
at slowing/halting PD progression. … Moreover, MPTP-induced degeneration of the nigrostriatal …

… for their therapeutic potential against Parkinson’s disease (PD… promising in the preclinical
studies using laboratory animal … acid in MPTPinduced Parkinsonian mouse model. Neurotox …

… GSK3b inhibition might be a good strategy for the treatment of neurodegenerative diseases.
… behavioral changes in an MPTP induced Parkinson’s disease mouse model. Front Aging …

… promising therapeutic target for these neurodegenerative … upon its deletion in the
MPTP-induced PD model. (d) The high … )-mediated Alzheimer’s disease (AD) animal models and …

… nigral neurons from acute MPTP-induced neurodegeneration. … findings regarding its
promising translational potential and … from neurodegeneration in the MPTP mouse model of PD. …